Decision tree analysis for evaluating disease activity in patients with rheumatoid arthritis

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease characterized by inflammatory synovitis. We developed a new disease activity evaluation system using important cytokines to help doctors better evaluate disease activity in patients with RA. Methods: Flow cytometry was used to detect the levels of seven cytokines. Then, the results were analyzed using an R language decision tree. Results: The levels of six cytokines, namely interleukin (IL)-2, IL-4, IL-6, IL-10, tumor necrosis factor-α, and interferon-γ, were significantly different between the active disease and remission stages. Decision tree analysis of the six cytokines with statistical significance identified two judgment rules for the remission stage and three judgment rules for the active disease stage. Conclusion: We proposed the use of the decision tree method to analyze cytokine levels in patients with RA and obtain a more intuitive and objective RA disease activity scoring system. This method revealed the relationships of IL-6 and TNF-α levels with inflammatory characteristics in patients with RA, which can help predict disease activity.

Cite

CITATION STYLE

APA

Wang, L., Zhu, L., Jiang, J., Wang, L., & Ni, W. (2021). Decision tree analysis for evaluating disease activity in patients with rheumatoid arthritis. Journal of International Medical Research, 49(10). https://doi.org/10.1177/03000605211053232

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free